Atlas Trials

Effectiveness & Tolerability of Novel, Initial Triple Combination Therapy vs Conventional Therapy in Type 2 Diabetes

Clinical trial NCT02946632 · UNKNOWN

Trial details

NCT number
NCT02946632
Sponsor
Korea University Anam Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type II
Start date
2016-12-01
Primary completion
2019-12-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.